agilon health (NYSE:AGL) Lowered to “Hold” at Deutsche Bank Aktiengesellschaft

agilon health (NYSE:AGL) was downgraded by research analysts at Deutsche Bank Aktiengesellschaft from a “buy” rating to a “hold” rating in a report released on Tuesday, Briefing.com reports. They currently have a $12.00 price objective on the stock, down from their prior price objective of $27.00. Deutsche Bank Aktiengesellschaft’s target price would indicate a potential upside of 4.21% from the stock’s current price.

Other research analysts have also recently issued research reports about the company. Truist Financial reduced their target price on agilon health from $27.00 to $23.00 and set a “buy” rating on the stock in a report on Thursday, November 9th. The Goldman Sachs Group decreased their target price on agilon health from $25.00 to $22.00 and set a “buy” rating for the company in a report on Thursday, November 9th. Wells Fargo & Company reduced their price target on shares of agilon health from $23.00 to $16.00 and set an “overweight” rating on the stock in a research report on Monday, November 13th. Royal Bank of Canada dropped their price objective on shares of agilon health from $28.00 to $23.00 and set an “outperform” rating for the company in a research report on Friday, November 3rd. Finally, TD Cowen decreased their price target on shares of agilon health from $29.00 to $25.00 and set an “outperform” rating for the company in a research report on Tuesday, August 15th. One equities research analyst has rated the stock with a hold rating and eight have given a buy rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $22.50.

agilon health Stock Performance

NYSE:AGL opened at $11.52 on Tuesday. The company has a market cap of $4.68 billion, a P/E ratio of -52.34 and a beta of 0.95. The firm’s 50 day moving average is $16.90 and its two-hundred day moving average is $18.31. agilon health has a fifty-two week low of $10.80 and a fifty-two week high of $29.44. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.04.

Insider Buying and Selling at agilon health

In other news, insider Benjamin Shaker sold 18,750 shares of agilon health stock in a transaction dated Tuesday, September 12th. The stock was sold at an average price of $18.05, for a total transaction of $338,437.50. Following the sale, the insider now directly owns 79,543 shares of the company’s stock, valued at $1,435,751.15. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. In other news, insider Benjamin Shaker sold 18,750 shares of the firm’s stock in a transaction that occurred on Tuesday, September 12th. The shares were sold at an average price of $18.05, for a total transaction of $338,437.50. Following the completion of the sale, the insider now owns 79,543 shares of the company’s stock, valued at $1,435,751.15. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CAO Timothy Gertsch sold 26,250 shares of the company’s stock in a transaction on Monday, September 11th. The shares were sold at an average price of $18.61, for a total transaction of $488,512.50. Following the completion of the sale, the chief accounting officer now directly owns 17,121 shares in the company, valued at $318,621.81. The disclosure for this sale can be found here. 3.60% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On agilon health

Several large investors have recently modified their holdings of the stock. Huntington National Bank raised its stake in agilon health by 241.3% during the second quarter. Huntington National Bank now owns 1,512 shares of the company’s stock valued at $26,000 after buying an additional 1,069 shares in the last quarter. Signaturefd LLC raised its position in shares of agilon health by 58.0% during the 1st quarter. Signaturefd LLC now owns 1,144 shares of the company’s stock valued at $27,000 after acquiring an additional 420 shares in the last quarter. CWM LLC raised its position in shares of agilon health by 83.7% during the 3rd quarter. CWM LLC now owns 1,585 shares of the company’s stock valued at $28,000 after acquiring an additional 722 shares in the last quarter. First Horizon Advisors Inc. lifted its stake in agilon health by 41.2% during the first quarter. First Horizon Advisors Inc. now owns 1,553 shares of the company’s stock worth $37,000 after purchasing an additional 453 shares during the last quarter. Finally, Ronald Blue Trust Inc. acquired a new position in agilon health in the third quarter worth $38,000.

agilon health Company Profile

agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2022, it served approximately 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.